310 related articles for article (PubMed ID: 17929246)
1. Serine racemase suppresses chondrogenic differentiation in cartilage in a Sox9-dependent manner.
Takarada T; Hinoi E; Takahata Y; Yoneda Y
J Cell Physiol; 2008 May; 215(2):320-8. PubMed ID: 17929246
[TBL] [Abstract][Full Text] [Related]
2. Interference with cellular differentiation by D-serine through antagonism at N-methyl-D-aspartate receptors composed of NR1 and NR3A subunits in chondrocytes.
Takarada T; Takahata Y; Iemata M; Hinoi E; Uno K; Hirai T; Yamamoto T; Yoneda Y
J Cell Physiol; 2009 Sep; 220(3):756-64. PubMed ID: 19452450
[TBL] [Abstract][Full Text] [Related]
3. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
4. Interference by adrenaline with chondrogenic differentiation through suppression of gene transactivation mediated by Sox9 family members.
Takarada T; Hojo H; Iemata M; Sahara K; Kodama A; Nakamura N; Hinoi E; Yoneda Y
Bone; 2009 Sep; 45(3):568-78. PubMed ID: 19446054
[TBL] [Abstract][Full Text] [Related]
5. SOX9 transduction increases chondroitin sulfate synthesis in cultured human articular chondrocytes without altering glycosyltransferase and sulfotransferase transcription.
Tew SR; Pothacharoen P; Katopodi T; Hardingham TE
Biochem J; 2008 Sep; 414(2):231-6. PubMed ID: 18433381
[TBL] [Abstract][Full Text] [Related]
6. Enamel matrix derivative stimulates chondrogenic differentiation of ATDC5 cells.
Narukawa M; Suzuki N; Takayama T; Shoji T; Otsuka K; Ito K
J Periodontal Res; 2007 Apr; 42(2):131-7. PubMed ID: 17305871
[TBL] [Abstract][Full Text] [Related]
7. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro.
Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J
Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932
[TBL] [Abstract][Full Text] [Related]
8. Osteoclastogenesis is negatively regulated by D-serine produced by osteoblasts.
Takarada T; Takarada-Iemata M; Takahata Y; Yamada D; Yamamoto T; Nakamura Y; Hinoi E; Yoneda Y
J Cell Physiol; 2012 Oct; 227(10):3477-87. PubMed ID: 22252936
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha.
Huang Z; Xu H; Sandell L
J Bone Miner Res; 2004 Feb; 19(2):245-55. PubMed ID: 14969394
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2-associated athanogene-1 (BAG-1): a transcriptional regulator mediating chondrocyte survival and differentiation during endochondral ossification.
Tare RS; Townsend PA; Packham GK; Inglis S; Oreffo RO
Bone; 2008 Jan; 42(1):113-28. PubMed ID: 17950682
[TBL] [Abstract][Full Text] [Related]
11. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability.
Kinkel MD; Horton WE
J Cell Biochem; 2003 Apr; 88(5):941-53. PubMed ID: 12616533
[TBL] [Abstract][Full Text] [Related]
12. Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage.
Asou Y; Nifuji A; Tsuji K; Shinomiya K; Olson EN; Koopman P; Noda M
J Orthop Res; 2002 Jul; 20(4):827-33. PubMed ID: 12168674
[TBL] [Abstract][Full Text] [Related]
13. Sox9 is required for cartilage formation.
Bi W; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
Nat Genet; 1999 May; 22(1):85-9. PubMed ID: 10319868
[TBL] [Abstract][Full Text] [Related]
14. Msx2 is a repressor of chondrogenic differentiation in migratory cranial neural crest cells.
Takahashi K; Nuckolls GH; Takahashi I; Nonaka K; Nagata M; Ikura T; Slavkin HC; Shum L
Dev Dyn; 2001 Oct; 222(2):252-62. PubMed ID: 11668602
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9.
Robins JC; Akeno N; Mukherjee A; Dalal RR; Aronow BJ; Koopman P; Clemens TL
Bone; 2005 Sep; 37(3):313-22. PubMed ID: 16023419
[TBL] [Abstract][Full Text] [Related]
16. Cartilage-derived retinoic acid-sensitive protein and type II collagen expression during fracture healing are potential targets for Sox9 regulation.
Sakano S; Zhu Y; Sandell LJ
J Bone Miner Res; 1999 Nov; 14(11):1891-901. PubMed ID: 10571689
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
18. Expression of transcription factor Sox9 in rat L6 myoblastic cells.
Matsushita T; Matsui N; Fujioka H; Kubo S; Kuroda R; Kurosaka M; Yoshiya S
Connect Tissue Res; 2004; 45(3):164-73. PubMed ID: 15512770
[TBL] [Abstract][Full Text] [Related]
19. [Chondrogenic differentiation and transcription factors].
Shinomura T
Clin Calcium; 2006 Mar; 16(3):494-8. PubMed ID: 16508134
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-3 negatively regulates chondrocyte differentiation.
Wakabayashi T; Matsumine A; Nakazora S; Hasegawa M; Iino T; Ota H; Sonoda H; Sudo A; Uchida A
Biochem Biophys Res Commun; 2010 Jan; 391(1):1116-21. PubMed ID: 20005202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]